These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1177408)

  • 1. Changes of fractional renal clearance of magnesium after spironolactone administration in normal subjects.
    Mountokalakis T; Merikas G; Skipelitis P; Vardakis M; Sevastos N; Alivisatos J
    Klin Wochenschr; 1975 Jul; 53(13):633-5. PubMed ID: 1177408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation by spironolactone of the magnesiuric effect of acute frusemide administration in patients with liver cirrhosis and ascites.
    Stergiou GS; Mayopoulou-Symvoulidou D; Mountokalakis TD
    Miner Electrolyte Metab; 1993; 19(2):86-90. PubMed ID: 8377729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal handling of magnesium in transplanted children under cyclosporin A treatment.
    Krull F; Hoyer PF; Offner G; Brodehl J
    Eur J Pediatr; 1988 Nov; 148(2):148-51. PubMed ID: 3069471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of spironolactone on the renal clearance of digoxin in dogs.
    O'Brien MS; Salamone LF; Gibson TP
    J Pharmacol Exp Ther; 1985 Jul; 234(1):190-4. PubMed ID: 4009501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effect of hydrochlorothiazide on renal calcium and magnesium handling in postmenopausal women.
    Stefíková K; Spustová V; Dzúrik R
    Physiol Res; 1999; 48(4):327-30. PubMed ID: 10638687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal function and magnesium clearance in young and old cows given potassium chloride and sodium citrate.
    Deetz LE; Tucker RE; Mitchell GE; DeGregorio RM
    J Anim Sci; 1982 Sep; 55(3):680-9. PubMed ID: 7130070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin-induced hypomagnesaemia and renal magnesium wasting in rats.
    Wong NL; Dirks JH
    Clin Sci (Lond); 1988 Nov; 75(5):509-14. PubMed ID: 3254764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on muscle electrolytes of potassium and magnesium infusions, spironolactone medication and operation in a case of primary aldosteronism.
    Dyckner T; Wester PO
    Acta Med Scand; 1979; 206(1-2):137-40. PubMed ID: 484255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome.
    Colussi G; Rombolà G; De Ferrari ME; Macaluso M; Minetti L
    Am J Nephrol; 1994; 14(2):127-35. PubMed ID: 8080005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal reabsorption of magnesium and calcium by cattle with renal tubular dysplasia.
    Ohba Y; Kitoh K; Nakamura H; Okuda H; Kunieda T; Sasaki Y; Kitagawa H
    Vet Rec; 2002 Sep; 151(13):384-7. PubMed ID: 12403519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of diuretics on the renal excretion of magnesium].
    Sotorník I; Schück O
    Cas Lek Cesk; 1975 Apr; 114(16):500-5. PubMed ID: 1131840
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose-dependent reduction in renal magnesium clearance by amiloride during frusemide-induced diuresis in rats.
    Devane J; Ryan MP
    Br J Pharmacol; 1983 Nov; 80(3):421-8. PubMed ID: 6640198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of an increase in the plasma potassium concentration on renal magnesium handling in healthy volunteers.
    de Valk HW; van Rijn HJ; Wielders JP; Koomans HA
    Nephrol Dial Transplant; 1998 Jan; 13(1):53-8. PubMed ID: 9481715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrarenal sodium handling during chronic spironolactone treatment.
    Roos JC; Dorhout Mees EJ; Koomans HA; Boer P
    Nephron; 1984; 38(4):226-32. PubMed ID: 6514071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silicon metabolism. I. Some aspects of renal silicon handling in normal man.
    Berlyne GM; Adler AJ; Ferran N; Bennett S; Holt J
    Nephron; 1986; 43(1):5-9. PubMed ID: 3703066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of spironolactone-induced gynecomastia.
    Rose LI; Underwood RH; Newmark SR; Kisch ES; Williams GH
    Ann Intern Med; 1977 Oct; 87(4):398-403. PubMed ID: 907238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary excretion of sodium and potassium after administration of aldosterone antagonist (Aldactone) in newborn infants and infants].
    Solc J
    Cesk Pediatr; 1974 Apr; 29(4):206-7. PubMed ID: 4830782
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects.
    Murdoch DL; Forrest G; Davies DL; McInnes GT
    Br J Clin Pharmacol; 1993 Apr; 35(4):373-8. PubMed ID: 8485017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnesium- and potassium-sparing effects of amiloride. Review and recent findings.
    Ryan MP
    Magnesium; 1984; 3(4-6):274-88. PubMed ID: 6536837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal calcium and magnesium handling in water immersion in nephrotic patients.
    Brown C; Sutton JV; Adler A; Feinroth MV; Feinroth M; Friedman EA; Berlyne GM
    Nephron; 1983; 33(1):17-20. PubMed ID: 6835450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.